Evidence map›Paper›PMID 38978500›Full record

ArticleACS nano2024

Engineering the Cellular Microenvironment: Integrating Three-Dimensional Nontopographical and Two-Dimensional Biochemical Cues for Precise Control of Cellular Behavior.

Einollah Sarikhani, Dhivya Pushpa Meganathan, Anne-Kathrine Kure Larsen, Keivan Rahmani, Ching-Ting Tsai, Chih-Hao Lu, Abel Marquez-Serrano, Leah Sadr, Xiao Li, Mingdong Dong and 4 more

Abstract read
In one paragraph

Article in ACS nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Einollah SarikhaniDepartment of NanoEngineering, University of California San Diego, La Jolla ,California 92093, United States.ORCID 0000-0002-7841-5244
Dhivya Pushpa MeganathanDepartment of NanoEngineering, University of California San Diego, La Jolla ,California 92093, United States.
Anne-Kathrine Kure LarsenInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C 8000, Denmark.
Keivan RahmaniDepartment of NanoEngineering, University of California San Diego, La Jolla ,California 92093, United States.
Ching-Ting TsaiDepartment of Chemistry, Stanford University, Stanford ,California 94305, United States.
Chih-Hao LuDepartment of Chemistry, Stanford University, Stanford ,California 94305, United States.
Abel Marquez-SerranoDepartment of NanoEngineering, University of California San Diego, La Jolla ,California 92093, United States.
Leah SadrDepartment of NanoEngineering, University of California San Diego, La Jolla ,California 92093, United States.
Xiao LiDepartment of Chemistry, Stanford University, Stanford ,California 94305, United States.ORCID 0000-0002-1200-8590
Mingdong DongInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C 8000, Denmark.ORCID 0000-0002-2025-2171
Francesca SantoroCenter for Advanced Biomaterials for Healthcare, Tissue Electronics, Instituto Italiano di Tecnologia, Naples 80125, Italy.ORCID 0000-0001-7323-9504
Bianxiao CuiDepartment of Chemistry, Stanford University, Stanford ,California 94305, United States.ORCID 0000-0002-8044-5629
Lasse Hyldgaard KlausenInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C 8000, Denmark.ORCID 0000-0003-3004-5958
Zeinab JahedDepartment of NanoEngineering, University of California San Diego, La Jolla ,California 92093, United States.ORCID 0000-0002-0139-3219

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of biomaterials capable of regulating cellular processes and guiding cell fate decisions has broad implications in tissue engineering, regenerative medicine, and cell-based assays for drug development and disease modeling. Recent studies have shown that three-dimensional (3D) nanoscale physical cues such as nanotopography can modulate various cellular processes like adhesion and endocytosis by inducing nanoscale curvature on the plasma and nuclear membranes. Two-dimensional (2D) biochemical cues such as protein micropatterns can also regulate cell function and fate by controlling cellular geometries. Development of biomaterials with precise control over nanoscale physical and biochemical cues can significantly influence programming cell function and fate. In this study, we utilized a laser-assisted micropatterning technique to manipulate the 2D architectures of cells on 3D nanopillar platforms. We performed a comprehensive analysis of cellular and nuclear morphology and deformation on both nanopillar and flat substrates. Our findings demonstrate the precise engineering of single cell architectures through 2D micropatterning on nanopillar platforms. We show that the coupling between the nuclear and cell shape is disrupted on nanopillar surfaces compared to flat surfaces. Furthermore, our results suggest that cell elongation on nanopillars enhances nanopillar-induced endocytosis. We believe our platform serves as a versatile tool for further explorations into programming cell function and fate through combined physical cues that create nanoscale curvature on cell membranes and biochemical cues that control the geometry of the cell.

Indexed as

Cellular MicroenvironmentAnimalsBiocompatible MaterialsCell AdhesionCell ShapeEndocytosisHumansNanostructuresSurface PropertiesTissue EngineeringBiocompatible Materialscell and nuclear deformationcell and nuclear mechanicscell and nuclear morphologymechanobiologymicropatterningnanopillarnanostructures

Identifiers

PMID38978500
PMCPMC11271182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.